3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
25
Multiple Myeloma
13
Prostatic Neoplasms
10
Osteoporosis
8
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
5
Fractures, Bone
4
Neoplasms, Plasma Cell
3
Lymphoma
3
Bone Diseases, Metabolic
3
Bone Diseases
3
Spinal Cord Compression
2
Pain
2
Ovarian Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Bone Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Pleural Effusion, Malignant
1
Paraproteinemias
1
Oligodendroglioma
1
Neoplastic Processes
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
Carboplatin
6
Paclitaxel
5
Taxes
3
Docetaxel
3
Cisplatin
3
Gemcitabine
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Bevacizumab
2
talimogene laherparepvec
1
saracatinib
1
romidepsin
1
rilotumumab
1
ganitumab
1
Zoledronic Acid
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Talc
1
Surveys and Questionnaires
1
Spectrum Analysis
1
Sodium Chloride
1
Pemetrexed
1
Nivolumab
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Immunohistochemistry
1
Imatinib Mesylate
1
Gefitinib
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Pleural Effusion, Malignant
×
Zoledronic Acid
×
Clear all
NCT01004510
2012-12-04
ZAP
Rochester General Hospital
Phase 2
Terminated
3 enrolled
5 charts